Lena Chaihorsky is the Co-Founder and Senior Vice President of Payor Innovation at Alva10, a Precision Medicine company that strategically partners the diagnostics industry with healthcare fiduciaries in order to bring diagnosis and prevention to the forefront of healthcare improvement.
Lena’s academic background in mathematics and biology led to a passion for redesigning the financial incentives of the healthcare system, with a focus on the underutilized area of diagnostics. Lena has over 15 years’ experience in the diagnostics industry, and is a nationally recognized market access and payment expert with a successful track record that spans both private and public companies.
Lena is a speaker and advocate for Precision Medicine and its ability to transform American healthcare into a stabilizing force for national wellness. Her work around mathematical modeling of diagnostic value led to her appointment as Chairwoman of the World Economic Forum’s Working Group on Federated Databases in Rare Disease, and to the Study Design Task Force for Pharmacogenomics at the American Society of Pharmacovigilance. She currently leads the Precision Medicine Task Force at NABIP, the leading professional organization for the brokers and consultants who shape employer-sponsored healthcare, and co-chairs the New Business Models Committee of Lab 2.0, a collaborative of the county’s top hospital labs, seeking novel business models that incentivize diagnosis and prevention of disease in the American public.
